Evidence map›Paper›PMID 36669105›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2023

Mammalian life depends on two distinct pathways of DNA damage tolerance.

Olimpia Alessandra Buoninfante, Bas Pilzecker, Aldo Spanjaard, Daniël de Groot, Stefan Prekovic, Ji-Ying Song, Cor Lieftink, Matilda Ayidah, Colin E J Pritchard, Judith Vivié and 9 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 2 countries.

Olimpia Alessandra BuoninfanteDivision of Tumor Biology and Immunology, The Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands.
Bas PilzeckerDivision of Tumor Biology and Immunology, The Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands.ORCID 0000-0002-3407-9197
Aldo SpanjaardDivision of Tumor Biology and Immunology, The Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands.ORCID 0000-0002-3189-6941
Daniël de GrootDivision of Tumor Biology and Immunology, The Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands.
Stefan PrekovicDivision of Oncogenomics, The Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands.
Ji-Ying SongDivision of Experimental Animal Pathology, The Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands.ORCID 0000-0002-6296-1996
Cor LieftinkDivision of Molecular Carcinogenesis, The Netherlands Cancer Institute Robotics and Screening Center, The Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands.
Matilda AyidahDivision of Tumor Biology and Immunology, The Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands.
Colin E J PritchardMouse Clinic for Cancer and Aging Research, Transgenic Facility, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Judith ViviéHubrecht Institute-Royal Netherlands Academy of Arts and Sciences, 3584 CT Utrecht, The Netherlands.
Kathleen E McgrathDepartment of Pediatrics, University of Rochester Medical Center School of Medicine and Dentistry, Rochester, NY 14642.
Ivo J HuijbersMouse Clinic for Cancer and Aging Research, Transgenic Facility, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Sjaak PhilipsenDepartment of Cell Biology, Erasmus Medical Center, 3015CN Rotterdam, The Netherlands.ORCID 0000-0002-3690-1201
Marieke von LindernDepartment of Hematopoiesis, Sanquin Research and Landsteiner Laboratories, 1066CX Amsterdam, The Netherlands.ORCID 0000-0001-6162-6320
Wilbert ZwartDivision of Oncogenomics, The Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands.
Roderick L BeijersbergenDivision of Molecular Carcinogenesis, The Netherlands Cancer Institute Robotics and Screening Center, The Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands.
James PalisDepartment of Pediatrics, University of Rochester Medical Center School of Medicine and Dentistry, Rochester, NY 14642.
Paul C M van den BerkDivision of Tumor Biology and Immunology, The Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands.ORCID 0000-0003-1213-253X
Heinz JacobsDivision of Tumor Biology and Immunology, The Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands.ORCID 0000-0001-6227-9850
The Netherlands Cancer Institute · NLUniversity of Rochester Medical Center · USErasmus MC · NLRoyal Netherlands Academy of Arts and Sciences · NLSanquin · NLUtrecht University · NL

Funding

KWF Kankerbestrijding (DCS) 10032KWF Kankerbestrijding (DCS) 10796
6 · The paper itself

Abstract

DNA damage threatens genomic integrity and instigates stem cell failure. To bypass genotoxic lesions during replication, cells employ DNA damage tolerance (DDT), which is regulated via PCNA ubiquitination and REV1. DDT is conserved in all domains of life, yet its relevance in mammals remains unclear. Here, we show that inactivation of both PCNA-ubiquitination and REV1 results in embryonic and adult lethality, and the accumulation of DNA damage in hematopoietic stem and progenitor cells (HSPCs) that ultimately resulted in their depletion. Our results reveal the crucial relevance of DDT in the maintenance of stem cell compartments and mammalian life in unperturbed conditions.

Indexed as

DNA DamageAnimalsDNA RepairDNA ReplicationHematopoietic Stem CellsMammalsProliferating Cell Nuclear AntigenUbiquitinationProliferating Cell Nuclear AntigenDNA damage response (DDR)DNA damage tolerance (DDT)embryonic lethalityerythropoiesishematopoietic stem cells

Identifiers

PMID36669105
PMCPMC9942833
OpenAlexW4317600676

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.